Arkolith/Insider Trading/INMB/Form 4

Ellspermann Cory Randall

Interim CFOInmune Bio, Inc. (INMB) · full profile →Form 4 · filed Nov 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 18, 2025Grant(A)75K——75K
Nov 18, 2025Disposed to issuer(D)75K——0
Nov 18, 2025Grant(A)30K——30K
Nov 18, 2025Disposed to issuer(D)40K——0
Nov 18, 2025Disposed to issuer(D)30K——0
Nov 18, 2025Grant(A)40K——40K
Nov 18, 2025Disposed to issuer(D)30K——0
Nov 18, 2025Grant(A)30K——30K
Nov 18, 2025Disposed to issuer(D)70K——0
Nov 18, 2025Grant(A)70K——70K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-112227) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Inmune Bio, Inc.

Build

Ask your agent about INMB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-25-112227"
Ask your agent
Use Arkolith to summarize insider buying and selling at Inmune Bio, Inc.
over the last 90 days and cite the filings.